Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
37%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
18%
ALSO IN MEDX
MEDX
28
HOLDINGS
39%
ALSO IN XLV
SECTOR DRIFT (XLV minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.2% | 13.9% | 11.2% | |
ABBVIE INC | 7.4% | 9.4% | 7.4% | |
JOHNSON & JOHNSON | 8.6% | 5.0% | 5.0% | |
MERCK & CO. INC. | 4.4% | 3.4% | 3.4% | |
AMGEN INC | 3.2% | 4.0% | 3.2% |
XLV Overweight Relative to MEDX
UNITEDHEALTH GROUP INC | 5.6% | |
ABBOTT LABORATORIES | 4.6% | |
THERMO FISHER SCIENTIFIC INC | 3.8% | |
JOHNSON & JOHNSON | 3.6% | |
INTUITIVE SURGICAL INC | 3.4% | |
BOSTON SCIENTIFIC CORP | 3.1% | |
GILEAD SCIENCES INC | 2.8% | |
STRYKER CORP | 2.7% | |
DANAHER CORP | 2.7% | |
MEDTRONIC PLC | 2.4% |
XLV Underweight Relative to MEDX
NOVARTIS AG-ADR | -7.1% | |
ALNYLAM PHARMACEUTICALS INC | -6.6% | |
ASTRAZENECA PLC-SPONS ADR | -5.4% | |
ALKERMES PLC | -4.0% | |
CRISPR THERAPEUTICS AG | -3.3% | |
IONIS PHARMACEUTICALS, INC. | -3.1% | |
ELI LILLY & CO | -2.8% | |
BRISTOL-MYERS SQUIBB CO | -2.7% | |
GLAXOSMITHKLINE PLC-SPON ADR | -2.6% | |
BIOGEN IDEC INC | -2.1% |